[at noodls] – Onyx Pharmaceuticals Reports Third Quarter 2012 Financial Results Kyprolis Net Sales of $18.6 Million in Launch Quarter; Stivarga Launch Underway in U.S….This is an abstract of the original noodl. To … moreView todays social media effects on ONXXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Onyx Pharmaceuticals Reschedules its Third Quarter 2012 Conference Call to November 1, 2012 at 1:30pm ET South San Francisco, CA. – Oct. 29, 2012 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced … moreView todays social media effects on ONXXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Onyx Pharmaceuticals to Report Third Quarter 2012 Financial Results after Market on October 30, 2012 — Conference Call and Webcast at 5:00 p.m. Eastern Time — South San Francisco, CA. – Oct. 16, 2012 … moreView todays social media effects on ONXXView the latest stocks trending across Twitter. Click to view dashboard […]
